Freddy A. Jimenez, SVP & General Counsel at Celldex Therapeutics, Inc. (CLDX), bought 430 shares at $46.28 ($20K) on 2021-08-11, disclosed to the SEC on 2021-08-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CLDX | SELL | 2024-06-05 | $538K | — | Filing → |